Fromkin Andrew J. 4
4 · Immunovant, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Fromkin Drew J
Director
Transactions
- Award
Common Stock
2023-04-12+12,523→ 101,008 total - Award
Stock Option (right to buy)
2023-04-12+16,260→ 16,260 totalExercise: $14.70Exp: 2033-04-12→ Common Stock (16,260 underlying)
Footnotes (3)
- [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
- [F2]The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- [F3]The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date.